Log in to save to my catalogue

Integrated results from the COPERNICUS and GALILEO studies

Integrated results from the COPERNICUS and GALILEO studies

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_abe61a8dab3843ceb1b6943df25dfc16

Integrated results from the COPERNICUS and GALILEO studies

About this item

Full title

Integrated results from the COPERNICUS and GALILEO studies

Publisher

New Zealand: Dove Medical Press Limited

Journal title

Clinical ophthalmology (Auckland, N.Z.), 2017-01, Vol.11, p.1533-1540

Language

English

Formats

Publication information

Publisher

New Zealand: Dove Medical Press Limited

More information

Scope and Contents

Contents

To report on the efficacy and safety of intravitreal aflibercept in patients with macular edema secondary to central retinal vein occlusion (CRVO) in an integrated analysis of COPERNICUS and GALILEO.
Patients were randomized to receive intravitreal aflibercept 2 mg every 4 weeks or sham injections until week 24. From week 24 to week 52, all intr...

Alternative Titles

Full title

Integrated results from the COPERNICUS and GALILEO studies

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_abe61a8dab3843ceb1b6943df25dfc16

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_abe61a8dab3843ceb1b6943df25dfc16

Other Identifiers

ISSN

1177-5467,1177-5483

E-ISSN

1177-5483

DOI

10.2147/OPTH.S140665

How to access this item